Searched for
ZANTAC
GSK settles another lawsuit on heartburn drug Zantac in CaliforniaGSK settled a lawsuit in California over its heartburn drug Zantac causing cancer. Thousands of lawsuits are still pending in California an...- Drugmaker GSK settles another California lawsuit on heartburn drug ZantacGlaxoSmithKline (GSK) has announced that it will confidentially settle another lawsuit in California regarding its discontinued heartburn d...
- Indian-made cold syrup sent to Iraq contains poison, test showsBloomberg shared the test results with the World Health Organization as well as Iraqi and Indian officials on July 8. The WHO told Bloomber...
- European shares post worst week in three months, Siemens Energy slumpsEuropean shares closed lower on Friday amid concerns of higher interest rates and inflation, prompted by central bank policy decisions thro...
- No plans to reintroduce Zinetac in India: GSKBritish drugmaker GSK said it has no plans to reintroduce its once top-selling heartburn medication Zinetac (ranitidine) brand in India, de...
- Will PLI help Indian pharma gain market share at cost of MNCs?Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...
- GSK sends notices to Akums, Associate over 'Zinetac' brandThe Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...
- Sanofi trial failure ends development of breast cancer treatment amcenestrantA trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an ...
- New toxic drug impurities detected in some heart pills in USThe impurities were found in blood pressure drugs which have been recalled in Canada as well as Europe earlier this year. U.S. officials he...
- Our drug Ranitidine is safe: Strides PharmaRanitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. In India, a host...
- Ranitidine under lens after carcinogen alertIn India, a host of companies including GalxoSmithKline & Sun Pharma sell over 180 versions of the drug.
- GlaxoSmithKline Pharma: Supply woes, new drug policy cause for concernUnder-performance is likely to continue in the quarter to June since the company expects the supply constraints to ease only by the end of ...
- Aurobindo receives USFDA approval for Ranitidine syrupAurobindo Pharma today said it has received approval from the US Food and Drug Administration (USFDA) to sell generic ulcer medicine raniti...
- Indian pharma cos close to blockbuster breakthroughIndian pharma majors may manage to market their first indi-genous "blockbuster drugs" or new chemical entities (NCEs) in the next four year...
- J&J takes over Pfizer’s OTC unitThe acquisition of Pfizer’s global over-the-counter (OTC) business by Johnson & Johnson (J&J) will have some impact on Pfizer India, though...
Load More
